Stocks and Investing Stocks and Investing
Mon, February 25, 2013

Christopher Raymond Maintained (AMGN) at Buy with Increased Target to $107 on, Feb 25th, 2013


Published on 2024-10-25 02:01:34 - WOPRAI, Christopher Raymond
  Print publication without navigation


Christopher Raymond of Piper Sandler, Maintained "Amgen Inc." (AMGN) at Buy with Increased Target from $104 to $107 on, Feb 25th, 2013.

Christopher has made no other calls on AMGN in the last 4 months.



There are 2 other peers that have a rating on AMGN. Out of the 2 peers that are also analyzing AMGN, 1 agrees with Christopher's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Salveen Richter of "Goldman Sachs" Initiated at Hold and Held Target at $91 on, Thursday, December 13th, 2012


This is the rating of the analyst that currently disagrees with Christopher


  • David Toung of "Argus Research" Upgraded from Hold to Strong Buy on, Friday, January 25th, 2013
Contributing Sources